Announcements Trials
Browse Landscape

Status

Completed 4Unknown 2Active not recruiting 1

Sponsor Class

OTHER 20INDUSTRY 7

Study Type

Interventional 417Observational 7

Sponsor

Cancer Type

Gastrointestinal 6Dermatologic 1

Conditions

Colorectal Neoplasms 4Recurrence 1Pancreatic Neoplasms 1Neutropenia 1Keratosis, Actinic 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Fluorouracil × Clear all
NCT02394834 2026-04-13

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Takeda

Active not recruiting
757 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05178745 2025-01-30

Resection Observatory

Sanofi

Completed
140 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03446872 2021-09-28

Post Marketing Surveillance Study for ONIVYDE® in South Korea

Servier

Completed
94 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02135887 2020-12-22

MB-6

Microbio Co Ltd

Unknown
184 enrolled
Gastrointestinal

Neutropenia, Colorectal Neoplasms

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT01506167 2018-05-14

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)

Hoffmann-La Roche

Completed
719 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡